Q03181 (PPARD_HUMAN) Homo sapiens (Human)

Peroxisome proliferator-activated receptor delta UniProtKBInterProSTRINGInteractive Modelling

441 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

55 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP401
2znq
homo-2-mer170-441
2×B7G; 2×401;
Assess
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…
7vwf
homo-2-mer171-441
2×B7G; 2×K55;
Assess
human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…
7vwh
homo-2-mer171-441
2×82K; 2×B7G;
Assess
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
3gwx
homo-2-mer171-441
2×EPA;
Assess
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
1gwx
homo-2-mer171-441
2×433;
Assess
Human PPAR delta ligand binding domain in complex with a synthetic agonist TIPP204
2znp
homo-2-mer170-440
2×B7G; 2×K55;
Assess
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…
7vwg
homo-2-mer172-441
2×B7G; 2×820;
Assess
Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with…
7vwe
homo-2-mer172-441
2×B7G; 2×81O;
Assess
Human Peroxisome proliferator-activated receptor (PPAR) delta in complexed with a potent and select…
5y7x
homo-2-mer173-441
2×8RR; 1×K; 2×CL; 1×PGO; 2×JZR;
Assess
Human PPAR delta ligand binding domain in complex with a synthetic agonist H11
7w0g
homo-2-mer173-441
2×85B;
Assess
Co-crystal structure of Inhibitor compound MA-211 in complex with human PPARdelta LBD
7f80
homo-2-mer171-439
2×1KF;
Assess
Human Nuclear Receptor-Ligand Complex 1
2awh
homo-2-mer174-441
2×B7G; 2×VCA;
Assess
Co-crystal structure of an Inhibitor in complex with human PPARdelta LBD
5zxi
homo-2-mer171-438
2×9LU;
Assess
PPARdelta complexed with an anthranilic acid partial agonist
3dy6
homo-2-mer172-439
1×IOD; 2×DY6;
Assess
Co-crystal structure of Inhibitor compound in complex with human PPARdelta LBD
5xmx
homo-2-mer172-438
2×89L;
Assess
Human PPAR delta ligand binding domain in complex with a synthetic agonist V1
8hf8
homo-2-mer173-439
2×LOO; 2×BOG;
Assess
Crystal Structure of PPAR-delta complex
3d5f
homo-2-mer175-441
2×L41;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 11
5u42
monomer170-440
3×B7G; 1×7SM; 2×PGO; 2×PEG;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 4
5u3t
monomer170-440
1×7UY; 1×B7G; 4×PGO; 2×PEG;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 7
5u3w
monomer170-440
2×B7G; 1×7U1; 4×PGO;
Assess
Crystal structure PPAR delta binding GW0742
3tkm
monomer171-441
1×GW0; 1×GOL;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 3
5u3s
monomer170-440
1×7V4; 1×B7G; 3×PGO; 1×PEG; 1×K;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 12
5u43
monomer170-439
1×7SS; 1×PGO; 2×PEG; 2×B7G;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 2
5u3r
monomer170-439
2×B7G; 1×7V1; 5×PGO; 3×PEG;
Assess
Human PPARdelta ligand-binding domain in complexed with GW501516
5u46
monomer170-439
2×B7G; 2×PGO; 1×PEG; 1×7T1;
Assess
Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd)LBD in Complex with DN…
6a6p
monomer171-440
1×9RF; 1×B7G; 1×PE3;
Assess
Crystal structure of PPAR delta complexed with GW2331
1y0s
monomer170-439
7×IOD; 1×331; 1×B7G;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 1
5u3q
monomer173-441
1×7UJ; 1×B7G; 5×PGO; 3×PEG; 1×K;
Assess
X-ray structure of human PPAR delta ligand binding domain-pemafibrate co-crystals obtained by co-cr…
7wgn
monomer173-441
1×P7F; 1×BOG;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 6
5u3v
monomer173-441
2×B7G; 1×7TY; 3×PEG; 1×PGO;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 9
5u3y
monomer171-439
2×B7G; 1×7U7; 2×PGO; 2×PEG;
Assess
Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Ful…
3gz9
monomer171-439
1×B7G; 1×D32;
Assess
Structure of PPARdelta with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid
3et2
monomer172-440
1×ET1; 3×1BO;
Assess
Structural basis for iloprost as a dual PPARalpha/delta agonist
3sp9
monomer173-441
1×IL2;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 10
5u3z
monomer172-439
1×7UA; 4×PGO; 2×PEG; 2×B7G;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 14
5u45
monomer174-441
1×B7G; 1×7SY; 1×PEG; 1×PGO;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 5
5u3u
monomer172-439
1×7TV; 1×PGO; 1×PEG; 1×B7G;
Assess
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…
2xyj
monomer173-440
2×WLM; 1×1PE;
Assess
X-ray structure of human PPAR delta ligand binding domain-bezafibrate co-crystals obtained by co-cr…
7wgl
monomer174-440
1×BOG; 1×PEM;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 8
5u3x
monomer173-439
1×7U4; 1×B7G; 2×PGO; 1×PEG;
Assess
PPARd complexed with a phenoxyacetic acid partial agonist
3peq
monomer173-439
1×3EQ; 2×JZR; 4×IOD;
Assess
X-ray structure of human PPAR delta ligand binding domain-lanifibranor co-crystals obtained by co-c…
8hul
monomer174-440
1×BJB;
Assess
3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2
2j14
monomer174-440
1×GNI;
Assess
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…
2xyw
monomer174-440
1×08S; 1×BOG;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 16
5u41
monomer174-439
1×7UG; 3×PEG; 4×PGO;
Assess
Human Nuclear Receptor-Ligand Complex 2
2b50
monomer175-440
1×CA; 2×B7G; 1×VCA;
Assess
MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
2gwx
monomer175-440
Assess
X-ray structure of human PPAR delta ligand binding domain-seladelpar co-crystals obtained by co-cry…
8huo
monomer174-439
1×KKB;
Assess
PPAR Delta in complex with azppard02
3oz0
monomer175-440
1×3OZ;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 15
5u40
monomer174-438
1×7UD; 3×PEG; 2×PGO; 1×B7G;
Assess
Human PPARdelta ligand-binding domain in complexed with specific agonist 13
5u44
monomer174-438
2×B7G; 2×PGO; 1×7SV;
Assess
Human Nuclear Receptor-Ligand Complex 1
2baw
monomer175-439
2×B7G; 1×VCA;
Assess
Ligand binding domain of PPAR delta receptor in complex with a partial agonist
2q5g
monomer174-438
1×1FA;
Assess
Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Act…
2xyx
monomer176-440
1×Z00; 1×BOG;
Assess
Solution structure of the C4-type zinc finger domain from human Peroxisome proliferator-activated r…
2env
monomer72-146
2×ZN;
Assess

10 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3dzy.1.Bmonomer0.7171-441
1×ZN;65.59
Assess
7wnh.4.Amonomer0.5774-440
1×ZN;27.88
Assess
7wnh.2.Amonomer0.5673-437
2×ZN;27.88
Assess
4nqa.1.Amonomer0.5569-438
2×ZN;31.27
Assess
3dzu.1.Amonomer0.5471-437
1×ZN;32.61
Assess
5uan.1.Amonomer0.5472-439
2×ZN;31.27
Assess
4iqr.2.Amonomer0.5272-439
2×ZN;29.75
Assess
7prw.1.Amonomer0.5269-439
2×ZN;21.32
Assess
4iqr.2.Bmonomer0.5272-439
2×ZN;29.75
Assess
7prv.1.Bmonomer0.5171-439
1×ZN;21.32
Assess

17 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23e00.1.Bmonomer0.6670-360
1×ZN;64.60
Assess
Isoform 25uan.1.Bmonomer0.5773-360
1×ZN;30.28
Assess
Isoform 27wnh.4.Amonomer0.5574-358
1×ZN;27.60
Assess
Isoform 27wnh.1.Amonomer0.5472-358
2×ZN;27.60
Assess
Isoform 24nqa.1.Amonomer0.5370-360
2×ZN;34.43
Assess
Isoform 23dzy.1.Amonomer0.5271-360
1×ZN;35.66
Assess
Isoform 33e00.1.Bmonomer0.7231-402
1×ZN;65.42
Assess
Isoform 37wnh.4.Amonomer0.5835-401
1×ZN;27.79
Assess
Isoform 37wnh.2.Amonomer0.5734-398
2×ZN;27.79
Assess
Isoform 33dzu.1.Amonomer0.5732-398
2×ZN;32.92
Assess
Isoform 34nqa.1.Amonomer0.5628-399
2×ZN;31.69
Assess
Isoform 35uan.1.Amonomer0.5533-400
2×ZN;31.69
Assess
Isoform 34iqr.2.Amonomer0.5333-400
2×ZN;29.25
Assess
Isoform 34iqr.2.Bmonomer0.5333-400
2×ZN;29.25
Assess
Isoform 34nqa.2.Amonomer0.5035-395
1×ZN;38.76
Assess
Isoform 43et2.1.Amonomer0.8374-342
1×ET1; 3×1BO;100.00
Assess
Isoform 43dzy.1.Bmonomer0.7236-343
60.91
Assess